Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-09
1995-09-19
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514322, 514333, 514338, 514383, 514394, 544370, 546194, 546199, 546271, 5483101, 548250, 548254, A61K 31415, C07D23506
Patent
active
054515831
ABSTRACT:
There are disclosed compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are defined in the specification; n is 1 to 3;
REFERENCES:
patent: 4808715 (1989-02-01), Boyle et al.
patent: 4880804 (1989-11-01), Carini
patent: 5039814 (1991-08-01), Shuman
patent: 5187168 (1993-02-01), Primeau
patent: 5210092 (1993-05-01), Oku et al.
patent: 5215994 (1993-06-01), Oku et al.
patent: 5234936 (1993-08-01), Primeau
patent: 5283242 (1994-02-01), Ellingboe
Chem. Abst. 115:232250c (1991).
Chem. Abst. 115: 159142n (1991).
Chem. Abst. 115:71602b (1991).
Chem. Abst. 114:228914j (1991).
Chem. Abst. 114:164233b (1991).
Chiu, A., Euro Jour. Pharma: 157, 13-21 (1988).
American Home Products Corporation
Grumbling Matthew V.
Seifert Arthur G.
Shah Mukund J.
LandOfFree
Substituted benzimidazoles and quinazolines as antihypertensives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzimidazoles and quinazolines as antihypertensives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzimidazoles and quinazolines as antihypertensives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1828284